Basal cell carcinoma (controls excluding all cancers)

C3_BASAL_CELL_CARCINOMA_EXALLC

No definition available.

Endpoint definition

FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 C44.01, C44.11, C44.21, C44.31, C44.41, C44.51, C44.61, C44.71, C44.81, C44.91
Hospital discharge: ICD-9 173[0-9]A
Cause of death: ICD-10 C44.01, C44.11, C44.21, C44.31, C44.41, C44.51, C44.61, C44.71, C44.81, C44.91
Cause of death: ICD-9 173[0-9]A
Cancer registry: Topography ICD-O-3 C44
Cancer registry: Morphology ICD-O-3 809[0-8]
Cancer registry: Behaviour codes 3

3 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

20506

diagram downward connector
C3_BASAL_CELL_CARCINOMA_EXALLC

Control definitions

Control exclude C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF9

Similar endpoints

Summary Statistics

Key figures

All Female Male
Number of individuals 20506 9679 10827
Unadjusted prevalence (%) 4.98 4.20 5.96
Mean age at first event (years) 66.65 65.05 68.08

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.47 [1.22, 1.76] 3.5e-5 3790
15 years 0.01 0.99 [0.87, 1.13] 8.9e-1 1748
5 years 0.00 1.89 [1.70, 2.10] 2.2e-32 1167
1 year 0.00 2.26 [1.94, 2.64] 2.9e-25 276

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: C3_BASAL_CELL_CARCINOMA_EXALLC – Basal cell carcinoma (controls excluding all cancers)
GWS hits: 88

Survival analyses between endpoints

Plot

before Basal cell carcinoma (controls excluding all cancers)
after Basal cell carcinoma (controls excluding all cancers)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Basal cell carcinoma (controls excluding all cancers)

Endpoint not on priority list, no data to show.